Evaluation the combination of amoxyclav with amikacin and ceftriaxone against <i>Escherichia coli</i> sepsis
Last updated: 25 Dec 2024
10.21608/mid.2023.206746.1516
Escherichia coli, gentamicin, Paracetamol, Sepsis, Amoxyclav
Falah
AL-Khikani
Hasan Obayes
Department of Medical Laboratory Technology, College of Medical Technology, The Islamic University, Najaf, Iraq. Department of Microbiology, Al-Shomali General Hospital, Babylon Health Directorate, Babylon, Iraq, Al-Furat Al-Awsat Technical University, Babylon Technical institute, Iraq
falahgh38@gmail.com
0000-0002-8890-7090
Haider
Abdullah
Yahya
Al-Furat Al-Awsat Technical University, Babylon Technical institute, Iraq
falahgh66738@gmail.com
Babylon
Haider
Karkaz
Mahdi
Al-Furat Al-Awsat Technical University, Babylon Technical institute, Iraq
falahgh334328@gmail.com
Hawraa
abdulhussein
Ali
Al-Furat Al-Awsat Technical University, Babylon Technical institute, Iraq
falaher5gh38@gmail.com
Babylon
5
4
51278
2024-11-01
2023-04-19
2024-11-01
1,425
1,430
2682-4132
2682-4140
https://mid.journals.ekb.eg/article_298572.html
https://mid.journals.ekb.eg/service?article_code=298572
18
Original Article
1,157
Journal
Microbes and Infectious Diseases
https://mid.journals.ekb.eg/
Evaluation the combination of amoxyclav with amikacin and ceftriaxone against <i>Escherichia coli</i> sepsis
Details
Type
Article
Created At
25 Dec 2024